Guidelines for UNANI Practitioners for COVID-19 Patients in Home Isolation
The COVID-19 pandemic has emerged as a public health challenge. The burden of disease and mortality are steadily increasing in many parts of the globe. Several social and economic factors are leading to devastating situations. Effective management to address this infection is still evolving and attempts are being made to integrate traditional interventions along with standard care....
The COVID-19 pandemic has emerged as a public health challenge. The burden of disease and mortality are steadily increasing in many parts of the globe. Several social and economic factors are leading to devastating situations. Effective management to address this infection is still evolving and attempts are being made to integrate traditional interventions along with standard care. Home isolation is applicable to confirmed COVID-19 cases which are asymptomatic or have mild symptoms, or to people who had a contact with suspected cases of the disease.
The Ministry of AYUSH has laid down the following guidelines for Unani practitioners with regard to Home Isolation. The major recommendations include
Management Guidelines for COVID-19 Patients in Home-Isolation
The common clinical features observed in mild COVID-19 cases include sore throat, mild fever, body-ache, nasal congestion, and dry cough. Although a variety of symptoms are being reported, many cases are asymptomatic and some uncommon clinical manifestations include loss of smell and taste as well. Some of the asymptomatic cases can be in the pre-symptomatic stage. Considering this possibility, the patient should observe evolving symptoms or signs. This watchfulness should not lead to undue anxiety.
Specific measures for COVID-19 Patients in Home isolation
| Stage/Condition | Clinical Presentation | Medicine | Dosage |
| Asymptomatic COVID-19 Patients | -- | Safuf Asgand | 5 gm once daily |
| Khameera Marwareed(Not recommended for diabetics) | 3-5 gm once daily | ||
| TiryaqArba(Not recommended for diabetics) | 3-5 gm with lukewarm water | ||
| Arq Ajeeb | 2-3 drops to be instilled in a bowl with hot water for immediate inhalation for 5 minutes twice daily | ||
| Mild COVlD-19 Positive patients |
| Unani Joshanda prepared from Unnab 5 no, Behidana 3 gm and Sapistan 9 no | Preparation of Decoction by boiling these medicines in 250 ml of water, until it remains half and filter it, take luke warm once daily in the morning |
| Nasal congestion/Headache | Arq Ajeeb | 2-3 drops to be instilled in bowl with hot water for immediate inhalation for 5 minutes twice daily | |
| Fatigue | Khameera Marwareed (Not recommended for diabetics) | 3-5 g once daily | |
| Fever | Hab e Mubarak | 2 g (pill) twice daily | |
| Sore Throat | Sharbat e Toot Siyah (Not recommended for diabetics) | 20 ml twice daily | |
|
| Laooq-e-Sapistan (Not recommended for diabetics) | 10 gm twice daily for above 12 years of age | |
| Diarrhoea | Safoof e Teen | 5-10 g | |
|
|
| Sharbat Belgiri (Not recommended for diabetics) | 15 ml twice daily |
General Guidelines:
1. Patients should follow physical distancing, respiratory and hand hygiene, and wear masks.
2. Steam inhalation and use of warm water at frequent intervals.
3. Avoid use of cold water and exposure to cold air
4. Adequate sleep (7-8 hours) should be takenand day time sleep especially after lunch may be avoided
5. Fumigation of patient's room with Sandal (Santalum album) and Kafoor (Cinnamomum camphora).
6. Keep the scalp covered
7. Avoid physical exertion
8. Gharghara (gargle) with lukewarm water/ 10-20 gm of pulp of Khayar shamber (Cassia fistula) boiled in 100 ml of water
Dietary Guidelines:
1. Avoidance from sour diets
2. Use of Kalonji (Nigella seeds), Lahsun (Garlic), Adrak (Ginger), Amla (Indian Gooseberry), Haldi (Turmeric) in sufficient quantity.
3. Prefer easily digestible diet 4. Oral intake of Maushaeer(Barley water)
5. Take adequate oral fluids like hot soups/ hot tea
Note: In case of any deterioration/ worsening of symptoms patient should be immediately referred to a dedicated COVID- 19 Management Health Care Centre.
References:
1. Agarwal R, Diwanay S, Patki P, Patwardhan B, Studies on Immunomodulatory Activity of WithaniaSomnifera (Ashwagandha) Extracts in Experimental Immune Inflammation, J Ethnopharmacol, 1999,67 (1), 27-35.
2. Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B, Studies on the Immunomodulatory Effects of Ashwagandha, J Ethnopharmacol, 1996, 50 (2), 69-76.
3. Verma SK, Shaban A, Purohit R, Chimata ML, Geeta Rai G, Verma OP, Immunomodulatory activity of Withaniasomnifera (L.), Journal of Chemical and Pharmaceutical Research, 2012, 4(1):559-561.
4. Davis L, Kuttan G, Immunomodulatory Activity of WithaniaSomnifera, J Ethnopharmacol, 2000, 71 (1-2), 193-200.
5. Fazlullah M, YNM, MakhzanulMufradatMaroofbaJamiulAdwiya, Royal Printing Press,Lucknow, p. 35.
6. Anonymous, 2013, Essential Drugs List-Unani Medicine, Ministry of AYUSH, New Delhi, 2-4.
7. Khan M.A. Rumooz-i-Azam, Vol. I, CCRUM:2006, page No. 116
8. Baghdadi, S, 2011, Al-Mughni fi Tadbir al-AmrazwaMa'rifa al-Ilalwa'lA'raz, 1st ed. Daru'l Minhaj, p. 623-624.
9. Khan MA, Iksir-i Azam, Vol IV, Matba Munshi Naval Kishore, Lucknow, YNM page No. 221
10. Min Zhou, Huan-Huan Xing, Yan Yang, Yue-De Wang, Kun Zhou, Wei Dong, GanPeng Li, Wei-Yao Hu, Qiang Liu, Xue-Mei Li, Qiu-Fen Hu, Three New Anthraquinones From the Twigs of Cassia fistula and Their Bioactivities, J Asian Nat Prod Res, 2017, 19 (11), 1073-1078.
11. Ghassani Yusuf, 1975, KitabulMutamadfi'lAdwiya al-Mufrada, Daru'lMarifa, Beirut, page 143
To read the full guidelines, click on the following link
https://www.ayush.gov.in/docs/Home Isolation COVID-19 Patients - Guidelines for UNANI Practitioners-converted.pdf
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd